AzTrials
AzTrials

Health Adult SubjectsAcaciaGluNCT07416643

The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans

A study testing incorporating acacia gum flour into commonly consume foods in people with Health Adult Subjects, run by King Abdulaziz University at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Abnormal postprandial blood glucose (PPG) is considered as a strong predictor for developing metabolic diseases worldwide. Nowadays, little understanding is available on how a carbohydrate-rich food matrix and the starch structures within interact with the gastrointestinal tract to help in controlling PPG. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Health Adult Subjects
What is being tested?
incorporating acacia gum flour into commonly consume foods
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteSaudi Arabia
Study dates
1 Jun 2023to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male and female self-reported healthy volunteers (aged 18 to 40 years)
  • Normal to overweight individuals (body mass index (BMI) 18.5-30 kg/m2) o BMI is equal to body weight (kg) divided by height squared (m2)

Who cannot join

  • History of substance abuse
  • Excessive alcohol intake
  • Pregnancy
  • Diabetes
  • Cardiovascular disease
  • Cancer
Show all 11Show fewer
  • Any gastrointestinal disease e.g. irritable bowel syndrome or inflammatory bowel disease
  • Kidney disease
  • Liver disease
  • Pancreatitis
  • Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • King Fahd Medical Research center

    Jeddah

Other trials in Saudi Arabia

About this study

Official title: The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans: a Pilot Study

Abnormal postprandial blood glucose (PPG) is considered as a strong predictor for developing metabolic diseases worldwide. Nowadays, little understanding is available on how a carbohydrate-rich food matrix and the starch structures within interact with the gastrointestinal tract to help in controlling PPG. In this investigation, the use Acacia gum enriched flour will be used to explore the effect of adding the gum as food supplement on PPG in healthy humans.

Being tested
incorporating acacia gum flour into commonly consume foods

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • incorporating acacia gum flour into commonly consume foodsDietary supplement

    incorporating acacia gum flour into commonly consume foods

Study groups in NCT07416643
Study groupRoleWhat they receive
Acacia gum incorporated biscuitsExperimentalAcacia gum incorporated biscuits
Receives: Dietary Supplement: incorporating acacia gum flour into commonly consume foods
control biscuitsNo interventioncontrol biscuits

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postprandial blood glucose

    Measured: 0 minutes and postprandial timepoints: 15 minutes, 30 minutes, 60 minutes,120 minutes,180 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2026
  2. Study start1 Jun 2023
  3. Primary completion30 Aug 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07416643
Sponsor's protocol ID
286-22
Other IDs
596-290-1443
Acronym
AcaciaGlu
Status last verified
Feb 2026
First submitted
30 Jan 2026
Last updated
18 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing incorporating acacia gum flour into commonly consume foods in people with Health Adult Subjects, run by King Abdulaziz University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postprandial blood glucose (time frame: 0 minutes and postprandial timepoints: 15 minutes, 30 minutes, 60 minutes,120 minutes,180 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in